• A small autism trial with the anti-purine drug Suramin produced dramatic symptom improvements, reigniting interest in the “cell danger response” and damage-associated molecular patterns (DAMPs) as metabolic drivers of neurodevelopmental disorders.

• A new biorxiv pre-print proposes that ordinary, non-motor enzymes can generate directional torque and reciprocating motion through substrate binding and catalysis alone, suggesting a plausible evolutionary path from simple catalysis to true molecular motors.

• Qualys released CVE-2017-1000367, a stack-clash vulnerability in Linux sudo that permits local privilege escalation; patches were issued the same day.

• taviso’s open-source “loadlibrary” project enables Windows DLLs to run on Linux by providing a PE loader and syscall shim, allowing closed-source Windows binaries to be analyzed on Unix systems.

• After Nanorex’s shutdown, the NanoEngineer-1 CAD codebase was rescued and is now maintained; discussion centered on why molecular nanotechnology efforts have shifted from mechanosynthesis toward DNA synthesis and protein engineering.

• Participants argued that protein-design progress is currently gated more by DNA synthesis costs (~$0.10–$0.30 per base) than by limitations in design software or theoretical understanding.

• Eric Drexler’s recent FHI technical report on “intelligence distillation” and AI containment was cited as evidence of his pivot from molecular nanotechnology toward AI safety research.

• “Pinecone” (serotiny.bio), a drag-and-drop browser tool for combinatorial protein-domain design, was highlighted as an example of simplified, accessible biodesign software.